Atlas Trials

Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Clinical trial NCT01313078 · COMPLETED

Trial details

NCT number
NCT01313078
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian NeoplasmsFallopian Tube NeoplasmsPrimary Peritoneal Neoplasms
Start date
2010-01-01
Primary completion
2011-09-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.